【摘要】：目的:觀察調(diào)補(bǔ)肝腎湯對H型高血壓(陰虛陽亢證)患者降低血清同型半胱氨酸水平、降低血壓、改善中醫(yī)證候等方面的臨床效果和安全性指標(biāo)。方法:選擇60例符和納入標(biāo)準(zhǔn)的H型高血壓病(陰虛陽亢證)患者,隨機(jī)分為對照組與治療組,每組各30例,兩組患者的年齡、性別、疾病嚴(yán)重程度等無統(tǒng)計(jì)學(xué)差異。對照組采取常規(guī)西藥治療,即馬來酸依那普利葉酸片10mg/0.8mg,一日一次。治療組口服馬來酸依那普利葉酸片10mg/0.8mg,一日一次,同時(shí)口服調(diào)補(bǔ)肝腎湯,一日三次。治療周期為30天,于治療前后觀察患者血清同型半胱氨酸水平、血壓及中醫(yī)證候指標(biāo),觀察結(jié)果運(yùn)用χ2檢驗(yàn),配對樣本運(yùn)用t檢驗(yàn)進(jìn)行統(tǒng)計(jì)分析。結(jié)果:1.血清同型半胱氨酸濃度比較,兩組在治療前血清同型半胱氨酸濃度無顯著性差異;治療后對照組血清同型半胱氨酸濃度為22.19±3.56umol/L,實(shí)驗(yàn)組血清同型半胱氨酸濃度為18.83±2.38 umol/L,實(shí)驗(yàn)組和對照組間比較P0.01,有極顯著差異,實(shí)驗(yàn)組降低血清同型半胱氨酸的效果顯著優(yōu)于對照組。2.治療總有效率:對照組總有效率為56.67%,治療組總有效率為86.67%,兩組組間比較P0.05,有顯著差異,治療組總有效率高于對照組;兩組治療前血壓對比P0.05,差異無統(tǒng)計(jì)學(xué)意義;兩組治療后血壓對比P0.05,有顯著差異;3.兩組治療前后中醫(yī)證候改善指標(biāo)比較,P0.05,有顯著差異,治療組對中醫(yī)證候改善優(yōu)于對照組;4.治療組和對照組患者在治療前后均未出現(xiàn)不良反應(yīng),安全觀察指標(biāo)比較無明顯差異。結(jié)論:調(diào)補(bǔ)肝腎湯治療H型高血壓(陰虛陽亢證)安全有效,能明顯改善患者中醫(yī)證候,能同時(shí)降低H型高血壓患者血壓和血清同型半胱氨酸水平,具有很高的臨床應(yīng)用價(jià)值和應(yīng)用前景。
[Abstract]:Objective: to observe the clinical effect and safety index of Tiaoguanshen decoction in reducing serum homocysteine level, lowering blood pressure and improving TCM syndromes in patients with H type hypertension (yin deficiency and yang hyperactivity syndrome). Methods: sixty patients with H type hypertension (yin deficiency and yang hyperactivity) were randomly divided into control group and treatment group with 30 cases in each group. There was no significant difference in age, sex and severity of disease between the two groups. The control group was treated with routine western medicine, that is, 10 mg / 0.8 mg folic acid tablets of enalapril maleate, once a day. In the treatment group, 10 mg / 0.8 mg folic acid tablets of enalapril maleate were given orally, once a day, and oral tonifying liver and kidney decoction, three times a day. The treatment period was 30 days. The serum homocysteine level, blood pressure and TCM syndromes were observed before and after treatment. The results were analyzed by 蠂 2 test and t test. The result is 1: 1. There was no significant difference in serum homocysteine concentration between the two groups before treatment. After treatment, the serum homocysteine concentration in the control group was 22.19 鹵3.56 umol/ L, the serum homocysteine concentration in the experimental group was 18.83 鹵2.38 umol / L, the difference between the experimental group and the control group was very significant (P 0.01). The effect of reducing serum homocysteine in the experimental group was significantly higher than that in the control group (.2.). The total effective rate of treatment: the total effective rate of the control group was 56.67 and the total effective rate of the treatment group was 86.67, the difference between the two groups was significant (P0.05), the total effective rate of the treatment group was higher than that of the control group, the blood pressure of the two groups was higher than that of the control group before treatment, the difference was not statistically significant. There was a significant difference in blood pressure between the two groups after treatment (P 0.05). There was significant difference between the two groups before and after treatment. The improvement of TCM syndrome in the treatment group was better than that in the control group (P 0.05). There were no adverse reactions before and after treatment in the treatment group and the control group, and there was no significant difference in the safety observation index between the treatment group and the control group. Conclusion: Tiaoguanshen decoction is safe and effective in treating H type hypertension (Yin deficiency and yang hyperactivity syndrome), it can obviously improve the syndrome of traditional Chinese medicine, decrease blood pressure and serum homocysteine level in patients with H type hypertension at the same time. It has high clinical application value and application prospect.
【學(xué)位授予單位】：云南中醫(yī)學(xué)院
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2017
【分類號】：R259

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 陳琦玲;;H型高血壓的機(jī)制與防治[J];中國全科醫(yī)學(xué);2015年11期

2 王進(jìn)京;方顯明;張明明;;H型高血壓病的中醫(yī)治療研究進(jìn)展[J];大眾科技;2014年11期

3 王金玲;;健脾化濁湯聯(lián)合西藥治療H型高血壓療效觀察[J];中國中醫(yī)藥信息雜志;2014年01期

4 黃偉明;;中醫(yī)淺析高同型半胱氨酸血癥[J];中醫(yī)臨床研究;2013年09期

5 李建華;符德玉;;H型高血壓中西醫(yī)研究進(jìn)展[J];人民軍醫(yī);2013年03期

6 張愛鵬;張華珊;張愛雄;;葛根素對冠心病患者血粘度及同型半胱氨酸影響觀察[J];中國實(shí)用醫(yī)藥;2012年30期

7 王承龍;談學(xué)平;駱吉鴻;;血漿HCY濃度水平與原發(fā)性高血壓中醫(yī)證型、血壓分級及病程相關(guān)性研究[J];遼寧中醫(yī)雜志;2012年09期

8 王強(qiáng);莫雪梅;韋斌;王慶高;方顯明;;天麻鉤藤飲聯(lián)合硝苯地平緩釋片對H型高血壓陰虛陽亢證的影響[J];疑難病雜志;2011年11期

9 王強(qiáng);何勁松;王慶高;方顯明;;H型高血壓與中醫(yī)證型的相關(guān)性探討[J];遼寧中醫(yī)雜志;2011年11期

10 劉力生;;中國高血壓防治指南2010[J];中國醫(yī)學(xué)前沿雜志(電子版);2011年05期

，

本文編號：2172427